AIM IMMUNOTECH INC (AIM) Stock Cash Flow
USA - NYSEARCA:AIM - US00901B3033 - Common Stock
1.7159 USD
-0.29 (-14.63%)
| TTM (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -16.17M | -17.32M | -28.96M | -19.45M | -19.13M | |||
| Depreciation Amortization | 240.00K | 246.00K | 238.00K | 256.00K | 775.00K | |||
| Change In Working Capital | 3.37M | 296.00K | 7.13M | 966.00K | 895.00K | |||
| Interest Paid | N/A | N/A | N/A | N/A | N/A | |||
| Other non cash items | 1.60M | 1.89M | 326.00K | 2.12M | 3.49M | |||
| OPERATING CASH FLOW | -10.96M | -14.89M | -21.27M | -16.11M | -13.96M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | N/A | -18.00K | -585.00K | -271.00K | -633.00K | |||
| Other Investing Activity | 5.99M | 4.72M | -247.00K | 11.26M | 2.00K | |||
| INVESTING CASH FLOW | 5.69M | 4.71M | -832.00K | 10.99M | -631.00K | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | 2.25M | N/A | 0.00 | -4.85M | |||
| Stock Issued/Repurchased | 2.06M | 4.20M | 485.00K | 80.00K | 13.04M | |||
| Other Financing Activity | N/A | N/A | N/A | N/A | N/A | |||
| FINANCING CASH FLOW | 2.19M | 6.44M | 485.00K | 80.00K | 8.19M | |||
| CHANGE IN CASH | -3.08M | -3.74M | -21.61M | -5.04M | -6.41M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -10.96M | -14.89M | -21.27M | -16.11M | -13.96M | |||
| Capital Expenditure | N/A | -18.00K | -585.00K | -271.00K | -633.00K | |||
| FREE CASH FLOW | -11.26M | -14.91M | -21.85M | -16.38M | -14.60M | |||
All data in USD